Novo-lela - Combo 1 - 4mg Semaglutide Vial & 4mg Cagrilintide Vial, now available at Slimgenix, is your ultimate partner in sustainable weight loss and enhanced well-being. Semaglutide and cagrilintide are often used together because both are injectable medications that target different pathways involved in appetite and weight regulation. Semaglutide, a GLP-1 receptor agonist, helps control blood sugar and reduce appetite, while cagrilintide, an amylin analogue, promotes satiety and slows gastric emptying. Transform your body with the synergistic effects of these powerful agents, providing reliable support tailored for your weight management journey. Embrace the future of health and well-being with Slimgenix.
Novo-lela - Combo 1 - 4mg Semaglutide Vial & 4mg Cagrilinitide Vial
R2 250,00Price
Semaglutide:
Week 1–4 Weekly dose of 0.25 mg 18 units
Week 5–8 Weekly dose of 0.5 mg 38 units
Week 9–12 Weekly dose of 1 mg 75 units
Week 13–16 Weekly dose of 1.7 mg 64 units Monday, 64 units Thursday.
Week 17 Weekly dose of 2.4 mg 90 units Monday, 90 units Thursday.
Week 13: It is recommended to switch to the Semaglutide 12mg/3ml for easier dosage.
Cagrilintide:
Dosage Instructions: Dose escalation Weekly dose Units to inject via insulin needle.
Week 1–4 0.25 mg 18 units
Week 5–8 0.5 mg 38 units
Week 9–12 1 mg 75 units.
